Pierre Fabre Medicament News
Most Popular Pierre Fabre Medicament Story
Forest Labs forges $75M deal for anti-depressant
Forest Laboratories has inked a deal to buy the North American rights to Pierre Fabre Medicament's experimental anti-depressant F2695 for $75 million. An undisclosed set of milestone payments are... Read more...
Latest Headlines
- February 2, 2010
- December 22, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
